Jordana Joy, Associate Editor

The report found that 68% of employees experience digital eye strain symptoms such as blurred vision, eye strain, and dry, itchy eyes, with 59% reporting affects to productivity.

Ben Young, OD, FAAO, sat down with Optometry Times for an exclusive interview on how he got to where he is today at the New England College of Optometry.

Milton Hom, OD, FAAO, took a deep dive into the lipid, aqueous, and mucin tear film layers to determine specialized treatment options for different types of dry eye.

Catch up on the top stories in optometry during the week of February 24-February 28.

HB 1352 will take effect in August 2025 with additional provisions to roll out based on plan renewals, contract changes, or by January 1, 2026.

The company also reported a positive outcome of an analysis of masked data from its ongoing MAGNIFY Phase 2 trial for zervimesine in adults with GA.

Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.

Updates include enrollments for LYNX-2 pivotal Phase 3 and VEGA-3 pivotal Phase 3 trials, in addition to a US FDA Fast Track Designation granted for phentolamine 0.75% for the treatment of significant chronic night driving impairment in keratorefractive patients with reduced mesopic vision.

Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.

The study examined changes in genes and proteins of the retinas of 9 strains of mice.

Alysse Henkel, vice president of Research and inSights at The Vision Council, advised that expanding budget and mid-market frame options may help improve frames sales.

Three EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.

The company plans to tap into Australia's preference for polarized sunglasses, which provides Revo with a gateway to establishing a customer base in Southeast Asia.

Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.

With an additional 10% increase in tariffs to China, and a 25% increase in tariffs in Canada and Mexico looming, the optical industry is anticipating paying as much as double in tariff costs compared to last year.

Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.

Among the top 20 contact lens-related searches on Google, 10 were purchase oriented and represented 65% of total volume.

Catch up on the top stories in optometry during the week of February 17-February 21.

John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.

Although 2025 is predicted to remain stable, the forecast for the optical industry still remains uncertain.

The study found that 17.4% of Medicare patients needed subspecialized procedures relative to 5.6% of surgeons practicing in rural areas between 2012 and 2022.

Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.

Prominent legislation includes the Corporate Transparency Act and last year's spending bill provision that was struck down.

Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.

Steven T. Reed, OD, talks Optometry's Meeting and public-facing initiatives that optometrists can take advantage of.

The study evaluated 13 teenagers and young adults who had high myopia (−6.50 to −9.25 D).

For Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, last week's conference gives a unique opportunity for optometrists and ophthalmologists to collaborate.

Steven T. Reed, OD, American Optometric Association's president, overviews the 2024 highlights and how the organization plans to extend success into 2025.

A total of 150 placements are for aspiring optometrists to shadow SpaMedica’s clinical teams and in-house optometrists as they treat patients.